Alyssa Matthews, OTR/L | |
6640 Kaniksu St, Bonners Ferry, ID 83805-7532 | |
(208) 267-3141 | |
Not Available |
Full Name | Alyssa Matthews |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 6640 Kaniksu St, Bonners Ferry, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720660160 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 072.0134180 (Vermont) | Secondary |
225X00000X | Occupational Therapist | OT-2893 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alyssa Matthews, OTR/L 46 Nichols St, Rutland, VT 05701-3275 Ph: (802) 775-2941 | Alyssa Matthews, OTR/L 6640 Kaniksu St, Bonners Ferry, ID 83805-7532 Ph: (208) 267-3141 |
News Archive
Computer scientists at the University of Southampton are using social networking tools to explore if individuals can enhance their personal and social wellbeing over time if they quickly share how they feel about issues such as their busyness, enjoyment, health and stress via these networks.
Vaccines for measles were not associated with an increased risk of febrile seizures among 4-6 year olds during the six weeks after vaccination, according to a study by the Kaiser Permanente Vaccine Study Center that appears in the current issue of Pediatrics.
The quality of hospitals across the United States is inconsistent. To address this issue, the federal government and private organizations have begun to publicly report data, such as how well hospitals treat certain conditions.
Smoking tobacco might be bad for your health, but a genetically altered version of the plant might provide a relatively inexpensive cure for the deadly rabies virus. In a new research report appearing in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants that was shown to neutralize the rabies virus.
The "grand experiment" of the Affordable Medicines Facility-malaria (AMFm) - a pilot program that aims to get artemisinin-based combination therapies (ACTs) into rural areas of several African nations - "seems likely to end, its successes underrated and potential improvements not yet explored," a Nature editorial says.
› Verified 8 days ago